Market Research Logo

Cardiovascular Drugs Market Global Briefing 2017Including: Anti-hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.Covering: Merck & Co., Sanofi, Pfizer, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly, John

Cardiovascular Drugs Market Global Briefing 2017Including: Anti-hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.Covering: Merck & Co., Sanofi, Pfizer, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly, Johnson & Johnson, AstraZeneca PLC, Abbott Laboratories Inc., Bayer AG

The global cardiovascular drugs market is expected to reach over $135 billion in 2020. The forecasted growth in this market can be attributed to the increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment.

Cardiovascular Drugs Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs sector.

Reasons to Purchase

  • Get up to date information available on the cardiovascular drugs market globally.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Cardiovascular Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the cardiovascular drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the cardiovascular drugs market and suggests approaches.

Scope

Markets Covered: Anti-hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.
Companies Mentioned: Merck & Co., Sanofi, Pfizer, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly, Johnson & Johnson, AstraZeneca PLC, Abbott Laboratories Inc., Bayer AG
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Cardiovascular Drugs Market Characteristics
Cardiovascular Drugs Market Historic Growth
Cardiovascular Drugs Market Forecast Growth
Cardiovascular Drugs Market Segmentation
Global Cardiovascular Drugs Market, Split By Segments, 2016, $ Billion
Anti-hypertensive Drugs
Hypolipidemics
Anti Thrombotics
Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segments, 2012-2020
Cardiovascular Drugs Market Geography Regional and Country Comparison
Global Cardiovascular Drugs Market, Split By Regions, 2016
Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Global Cardiovascular Drugs Market, Split By Country, 2016
Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Cardiovascular Drugs Market Competitive Landscape
Merck & Co.
Sanofi
AstraZeneca PLC
Novartis AG
Johnson & Johnson
Eli Lilly
Abbott Laboratories Inc.
Bayer AG
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Sanofi
Pfizer
Cardiovascular Drugs Market Key Mergers And Acquisitions
Teva Acquired Allergan’s Generic Business
Pfizer Acquired Hospira
AstraZeneca Acquired ZS Pharma
AstraZeneca Acquired Omthera Pharmaceuticals
Bristol-Myers Squibb Acquired Cardioxyl Pharmaceuticals
Cardiovascular Drugs Market Trends And Strategies
Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis
Approval Of New Drugs For Treatment Of Chronic Heart Failure
Personalized Medicine For Treatment Of Cardiovascular Disorders
Big Data
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Cardiovascular Drugs Market, Historic Market Size, 2012-2016, $ Billion
Figure 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Cardiovascular Drugs Market, Split By Segments, 2016, $ Billion
Figure 4: Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Figure 5: Global Cardiovascular Drugs Market, Split By Region, 2016, $ Billion
Figure 6: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Figure 7: Global Cardiovascular Drugs Market, Split By Country, 2016, $ Billion
Figure 8: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Figure 9: Global Cardiovascular Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)
List of Tables
Table 1: Global Cardiovascular Drugs Market, Historic Market Size, 2012-2016, $ Billion
Table 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Cardiovascular Drugs Market, Split By Segments, 2016, $ Billion
Table 4: Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Table 5: Global Cardiovascular Drugs Market, Split By Region, 2016, $ Billion
Table 6: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Table 7: Global Cardiovascular Drugs Market, Split By Country, 2016, $ Billion
Table 8: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Table 9: Global Cardiovascular Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report